• Racial/Ethnic Disparity in HRQoL- Implications of Social Support and Social Connectedness in Thyroid Cancer Care

    May 1, 2018, 00:00

  • Real-World Data Analysis of Confirmatory Biopsy Utilization in Suspected Prostate Cancer Patients

    May 1, 2018, 00:00

  • Do Words Matter? Patient Perspetives on Conceptually Similar Symptoms and Impacts Frequently Utilized in Patient-Reported Outcome (PRO) Measures

    May 1, 2018, 00:00

  • Cognitive Decline with Anticholinergic Medication Use Among Elderly Nursing Home Residents with Depression

    May 1, 2018, 00:00

  • Predictive Model for Earlier Diagnosis of Dementia Using Administrative Claims

    May 1, 2018, 00:00

  • Is Medication Adherence A Mediator of the Relationship Between Race/Ethnicity and Healthcare Cost in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Projecting survival with cure mixture models- when are the data mature enough for reliable analysis?

    May 1, 2018, 00:00

  • Efficacy and Safety of Atosiban in Pregnant Women Under Threat of Preterm Labor- Systematic Review

    May 1, 2018, 00:00

  • Cost Analysis Of Lipid Goal Attainments And Their Relationship With Clinical Outcomes In Chinese Post-Percutaneous Coronary Intervention Acute Coronary Syndrome Patients

    May 1, 2018, 00:00

  • Characteristics of Patients Receiving Dmard Therapy for Rheumatoid Arthritis Management

    May 1, 2018, 00:00

  • Is the Orphan Drug Act Being used as a Loophole to Extend Periods of Drug Exclusivity?

    May 1, 2018, 00:00

  • Community Oncology Perceptions And Views On Genomic Testing In The Era Of Precision Oncology

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Smoking Cessation Interventions in Malaysia

    May 1, 2018, 00:00

  • Evaluation Of Meaningful Change In Patient-Related Outcomes For Patients With Cutaneous T-Cell Lymphoma

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China

    May 1, 2018, 00:00

  • Economic Impact of Laparoscopic Vs Open Low Anterior Resection for Rectal Cancer Surgery- A Budget Impact Analysis

    May 1, 2018, 00:00

  • Quantifying the Importance of Model Parameters and Structural Assumptions on the Value of Treatments for Rheumatoid Arthritis Using Metamodeling

    May 1, 2018, 00:00

  • The Relationship Between Medical Insurance Coverage and Medication Payments in The US from 1997 to 2015

    May 1, 2018, 00:00

  • Availability of Pharmacies Participating in the 340B Drug Pricing Program, 2016

    May 1, 2018, 00:00

  • Medication Use Before and after Hospitalization for COPD in a Cohort of Elderly Patients with Medicare Advantage Plan

    May 1, 2018, 00:00

  • Aligned Strategies Identified by Prescribers and Managed Care to Close Treatment Decision Gaps in HCV and HIV

    May 1, 2018, 00:00

  • Asthma-COPD Overlapping as a Risk Factor for Healthcare Utilizations Among Adults with Asthma

    May 1, 2018, 00:00

  • Economic Value of Genetic Testing for Cancer Drugs with Clinically Relevant Drug-Gene Associations- A Systematic Literature Review

    May 1, 2018, 00:00

  • Ablation Procedure Using Newer Radiofrequency Catheters (Thermocool® SF Catheter or Thermocool Smarttouch® Catheter) Versus Earlier Generation Thermocool® Catheter- A Real-World Comparison of Outcomes Using a us Hospital Database

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Rivaroxaban Versus Warfarin For Treatment Of Nonvalvular Atrial Fibrillation In Patients With Worsening Renal Function

    May 1, 2018, 00:00

  • Analysis of Performance to Maximise Effectiveness of Resource Allocation in an Integrated Care Team Plan

    May 1, 2018, 00:00

  • Patient-Reported Outcome Use And Completion Information In Non-Randomized Cancer Trials

    May 1, 2018, 00:00

  • Systematic Literature Review of Real-World Evidence on Persistence, Switching, and Dose Escalation with Biologics in Inflammatory Bowel Disease in the United States

    May 1, 2018, 00:00

  • Synthetic Sample Generation Representing the English Population Using Spearman Rank Correlation and Chomsky Decomposition

    May 1, 2018, 00:00

  • Annual Change in Controlled Substance Opioid Prescribing and Concomitant Medications from an Urban Academic Emergency Department from 2011 – 2016

    May 1, 2018, 00:00

  • Vost Effectiveness of Blinatumomab Vs Inotuzomab Ozogamicin (INOTUZUMAB) in Adult Patients with Relapsed or Refracory (R/R) Acute Lymphoblastic Leukemia (ALL) with Zero or One Prior Salvage Therapy (S0/S1) from a US Payer Perspective

    May 1, 2018, 00:00

  • The Benefits and Costs Of Different Scenarios for Varicella Vaccination in Chile

    May 1, 2018, 00:00

  • Social Media Listening for Patient Risk Characterization

    May 1, 2018, 00:00

  • Identifying Cancer Trials That Incorporate Patient-Reported Outcome Measures- Comparing Fda Study Reports To Clinicaltrials.Gov

    May 1, 2018, 00:00

  • Health-Related Quality of Life Assessments Predict Relapse or Death in Patients with Newly Diagnosed Multiple Myeloma (MM)- Results from the Connect® MM Registry

    May 1, 2018, 00:00

  • Assessment of the Use of Pharmacogenetics in the Diagnosis and Treatment of Schizophrenia- Results from a Survey of Psychiatrists

    May 1, 2018, 00:00

  • Insurance Marketplace Enrollment and In-Person Assistance Under the Affordable Care Act

    May 1, 2018, 00:00

  • Patient Definitions of Improvement- Most Frequent Reasons for Defining Disease Improvement as Reported by Patients with Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Depression or Osteoarthritis (OA)

    May 1, 2018, 00:00

  • Impact of Medical Marijuana Legalization on Opioid use, Chronic Opioid use and High-Risk Opioid use

    May 1, 2018, 00:00

  • Drug Use Among Seniors in Canada, 2016

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Tafluprost/Timolol Maleate for Lowering Intraocular Pressure (IOP) in Adult Patients with Open-Angle Glaucoma or Ocular Hypertension in Bulgaria

    May 1, 2018, 00:00

  • Implementation of the South African Triaging Scale (SATS) System in Eastern Ghana- Assessment of Deployment at the Emergency Department of a Regional Hospital, 2015

    May 1, 2018, 00:00

  • Does the Timing of a Drug’s Costs and Benefits Influence us Payer Coverage of Special Drugs?

    May 1, 2018, 00:00

  • Salary Benchmarks and Compensation Disparity Among Global Health Economics and Market Access (HEORMA) Professionals Based on a 2017 Self-Report Survey

    May 1, 2018, 00:00

  • What is the Cost of a Breast Cancer Therapy Infusion? Real World Data on Brazilian Private Healthcare Perspective

    May 1, 2018, 00:00

  • Increased Healthcare Utilization in Dementia Subtypes Prior to Diagnosis

    May 1, 2018, 00:00

  • Impact of Human Papillomavirus (HPV) Etiology and Immuno-Oncology Therapy (IO) Availability on the Patient Journey In Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    May 1, 2018, 00:00

  • Clinical And Economic Burden Of Distributive Shock In US Intensive Care Units In 2014

    May 1, 2018, 00:00

  • Variation In Locoregional Treatment Of Stage I – II Breast Cancer By Breast Subtype In Nonelderly Adult Women

    May 1, 2018, 00:00

  • Developing A Consolidated Checklist (Strwe-Retro) to Assess the Reporting Quality of Real World Evidence Studies Based on Retrospective Data Analyses

    May 1, 2018, 00:00

  • Real-World Infection and Non-Union Rates Associated With Closed or Open Fractures of the Tibial Shaft Requiring Open Reduction and Internal Fixation

    May 1, 2018, 00:00

  • Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada

    May 1, 2018, 00:00

  • Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors

    May 1, 2018, 00:00

  • Comparison of Economic and Clinical Outcomes Between Skin Staples Plus Wound Dressings and 2-Octyl Cyanoacrylate Plus Polymer Mesh Tape Among Patients Undergoing Cesarean Section

    May 1, 2018, 00:00

  • Use Of Real-World Evidence In Clinical Decision Making By Community Oncologists

    May 1, 2018, 00:00

  • Sizing of the Migraine Population Treated with Preventive Medications for Migraine

    May 1, 2018, 00:00

  • Economic Value of Precision Medicine- An Example of Asthma

    May 1, 2018, 00:00

  • Incidence of Reoperations after Laparoscopic Bariatric Surgery

    May 1, 2018, 00:00

  • Mandatory Meningococcal Serogroup B Vaccination for College Students is Not Cost-Effective

    May 1, 2018, 00:00

  • Transporting the Results of A Clinical Trial to a New Target Population

    May 1, 2018, 00:00

  • Burden of Genital Warts in Colombia- An Observational Study

    May 1, 2018, 00:00

  • Analysis of Cost for Art Cycles in Ukraine

    May 1, 2018, 00:00

  • Systematic Review of the Direct Cost of Lung Cancer in China

    May 1, 2018, 00:00

  • Efficiency Test of Injury Prevention Program Among Junior Female Handball Players

    May 1, 2018, 00:00

  • Navigating Real World Evidence in Oncology – Where to Go and Why

    May 1, 2018, 00:00

  • Steroid-Eluting Sinus Implant Versus Revision Surgery for Patients with Recurrent Chronic Rhinosinusitis with Nasal Polyps (CRSWNP)- An Economic Evaluation Model

    May 1, 2018, 00:00

  • Using Private Claims Data to Study the Cost of the Opioid Crisis

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis Of Amisulpride And Olanzapine For Patients With Schizophrenia in China

    May 1, 2018, 00:00

  • Health Expenditure Comparison of Diabetic Patients on Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Vs Dipeptidyl Peptidase-4 (DPP4) Inhibitors

    May 1, 2018, 00:00

  • The Impact of Lifting Government Price Controls on Global Pharmaceutical Innovation and Population Health

    May 1, 2018, 00:00

  • Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A

    May 1, 2018, 00:00

  • The Current Landscape and Future of Outcomes-Based Contracting with Commercial Healthcare Payers in the US

    May 1, 2018, 00:00

  • Regional Variations in the Prevalence of Opioid use Disorders, Treatment Among Pregnant Women, And Newborns with Adverse Outcomes in a Commercially Insured Pregnant Population

    May 1, 2018, 00:00

  • The Cost-Effectiveness of a Public Health Nurse Program to Screen for Amblyopia in Ontario

    May 1, 2018, 00:00

  • Rapid Dissemination of H. Pylori Eradication for Chronic Gastritis Among Asymptomatic People

    May 1, 2018, 00:00

  • Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada

    May 1, 2018, 00:00

  • Use of the Weibull Proportional Hazards Model to Estimate OS and PFS in 9 Blood Cancer Indications- Validation and Violation

    May 1, 2018, 00:00

  • Risk of Respiratory Depression and Chronic Obstructive Pulmonary Disease Exacerbation in Older Adults with Concomitant Use of Opioids and Sedatives

    May 1, 2018, 00:00

  • Benchmarking HIV Quality Measures in the US Opera HIV Cohort

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Anti-Diabetic Regimens in T2DM Patients Unexpectedly Maintain Their Hypoglycemic Regimens for a Long Duration- A Retrospective Clinical Data Analysis Study

    May 1, 2018, 00:00

  • A Network Meta-Analysis of the Efficacy and Safety of Baloxavir Marboxil Suggests a Better Control of the Viral Load Versus Neuraminidase Inhibitors in the Treatment of Influenza in Otherwise Healthy Patients

    May 1, 2018, 00:00

  • Something is Better Than Nothing- The Value of Active Intervention on Stated Preferences for Treatments to Delay Onset of Alzheimer’s Disease Symptoms

    May 1, 2018, 00:00

  • Incremental Effect of Quality Blue Practices on Disease Management in Louisiana

    May 1, 2018, 00:00

  • Quality Of Life Of Patients With Cancer Undergoing Chemotherapy In Belo Horizonte Hospitals

    May 1, 2018, 00:00

  • Similarities and Differences in European HTA Evidence Requirements- One for All or One for None?

    May 1, 2018, 00:00

  • Identifying and Assessing the Feasibility of Proposed Alternative Approaches to Qaly Estimation Within Cost-Effectiveness Models Using a Systematic Literature Review

    May 1, 2018, 00:00

  • Economic Modeling Considerations for Rare Diseases

    May 1, 2018, 00:00

  • Opioid Overdose Risk Factors- A Matched Case Control Study in Mississippi Medicaid

    May 1, 2018, 00:00

  • Review and Validation of Cardiovascular Risk Prediction Models in East Asian Populations

    May 1, 2018, 00:00

  • A Validation of Piecewise Structural Equation Modelling (SEM) Compared to Traditional Structural Equation Modelling- A Simulation Study

    May 1, 2018, 00:00

  • Global Prevalence of Nonalcoholic Steatohepatitis (NASH)- Findings from a Targeted Literature Review

    May 1, 2018, 00:00

  • Baseline Health Utility Scores in Subjects with Suspected Ocular Disease- An Interim Analysis of the Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

    May 1, 2018, 00:00

  • The Incremental Cost of Post-Surgical Complications Following Breast Surgery

    May 1, 2018, 00:00

  • The Cost-Effectiveness of Ustekinumab Compared to Infliximab And Adalimumab in Adult Patients with Moderate-Severe Crohn's Disease (Tnf Naïve Population)

    May 1, 2018, 00:00

  • Comparative Effectiveness of Mtm Eligibility Criteria Under ACA and Mma Across Racial and Ethnic Groups in Medicare

    May 1, 2018, 00:00

  • Patient Reported Outcomes in Psoriasis Treatment Decision Making- A Discrete Choice Experiment Survey of Dermatologists in the Us

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sarilumab Versus Adalimumab for Treating Patients with Active Rheumatoid Arthritis- A Markov Model Assessment

    May 1, 2018, 00:00

  • The Impact of Post-Diagnosis Depression on Survival and Healthcare Costs for Patients Diagnosed with Late-Stage Cancer in the United States

    May 1, 2018, 00:00

  • Automation in Systematic Literature Review- Currently Available Technologies and Deployment Challenges

    May 1, 2018, 00:00

  • Efficacy and Safety of Biosimilar Insulins Compared to Their Reference Products- A Systematic Review

    May 1, 2018, 00:00

  • The Effectiveness of Integrated Treatment of Generalized Periodontitis for Patients with Chronic Hepatitis C

    May 1, 2018, 00:00

  • The Impact of a Value-Based Insurance Design for Chronic Preventive Medications on Adherence and Persistence in an Integrated Delivery System

    May 1, 2018, 00:00

  • The Cost-Effectiveness Analysis of Using Chromoagar for Active Surveillance of Carbapenem-Resistant Acinetobacter Baumannii to Determine the Duration of Contact Isolation in Intensive-Care Unit

    May 1, 2018, 00:00

  • Agreement Between FDA Approved Drug Label and Performance-Based Risk-Sharing Arrangement Endpoints

    May 1, 2018, 00:00

  • The Cost Effectiveness of a Patient Education Mobile Platform in Preventing Mother to Infant Transmission of Hepatitis B in the Chinese Population

    May 1, 2018, 00:00

  • A Cost Effectiveness Analysis (CEA) of Phenytoin (PHT) Versus Levetiracetam (LEV) for Early Seizure Pharmacoprophylaxis after Traumatic Brain Injury (TBI) from A US Institutional Perspective- An Upgrade of a Cost Minimization Analysis (CMA) ...

    May 1, 2018, 00:00

  • One Decade Cost of Cancer Treatment in Brazil and Its Determinants

    May 1, 2018, 00:00

  • The Evaluation of Adherence to Treatment and Real-World Outcomes in Two Cohorts of Patients with Serious Mental Illness (SMI)

    May 1, 2018, 00:00

  • The Use of Machine Learning to Boost Identification of Atrial Fibrillation and Increase Appropriate Utilization of Anticoagulant Drugs

    May 1, 2018, 00:00

  • Incidence of Malignant Neoplasm for Patients Using Biologic Drugs- A Nested Case-Control Study Using Medicare 5% Sample Datasets

    May 1, 2018, 00:00

  • Incidence of Subsequent Lumbar Surgery Following Posterior Lumbar Fusion

    May 1, 2018, 00:00

  • Impact of Biosmilars on the Price and Access of Originators in Major Autoimmune Indications- An Eu5 Perspective

    May 1, 2018, 00:00

  • Evaluating The Burden Of Prostate Cancer On Healthcare Utilization,Cost And Health Status Using Medical Expenditure Panel Survey- A Propensity Matched Score Analysis

    May 1, 2018, 00:00

  • Estimated Reduction in Medication Cost During first Year of a Continuous Care Intervention for Treatment of Type 2 Diabetes

    May 1, 2018, 00:00

  • Systematic Review of Endobronchial Ultrasonography with Guide Sheath

    May 1, 2018, 00:00

  • Patient Reported Treatment Satisfaction With Palbociclib Combination Therapies For HR+/HER2– Advanced Or Metastatic Breast Cancer In Multiple Countries

    May 1, 2018, 00:00

  • Hysterectomies Frequency in a Population Affiliated to a Public Health Insurer in Colombia; 2012 - 2016

    May 1, 2018, 00:00

  • The Prevalence and Predictors of Concomitant use of Tyrosine Kinase Inhibitors and Proton Pump Inhibitors in Older Adults with Cancer- An Observational Study Using Seer-Medicare Data

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimise Treatment Duration in Genotype 1 Non-Cirrhotic Treatment-Naïve Patients with Chronic Hepatitis C Virus

    May 1, 2018, 00:00

  • Use of Multiple Concurrent Antipsychotics and Adverse Events Related to Antipsychotics in Children and Adolescents Enrolled in Mississippi Medicaid

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis (CEA) Of Cetuximab+Folfiri Compared to Bevacizumab+Folfiri as First-Line Treatment of Ras Wild-Type (WT) Metastatic Colorectal Cancer (MCRC)- A US Analysis Based on Location of Primary Tumor

    May 1, 2018, 00:00

  • Rare Diseases- Addressing the Challenges in Diagnosis, Drug Approval, and Patient Access

    May 1, 2018, 00:00

  • Economic Consequences of Anti-HCV Antiviral Treatment Investment from the NHS Perspective

    May 1, 2018, 00:00

  • Designing and Implementing A New Model of Nutrition Care for Hospitalized Colombian Patients

    May 1, 2018, 00:00

  • Secukinumab Prescribing Patterns in Patients with Ankylosing Spondylitis in the United States- Data from Secukinumab Service Request Forms

    May 1, 2018, 00:00

  • Characteristics Glycemic Response of Patients With Uncontrolled Type 2 Diabetes Initiating Dulaglutide Alone or In Combination with Insulin In US Real World Practice

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of a First-in-Class, Triple Fixed Dose Combination Therapy Against Laba/Lama Therapy in Moderate-Severe COPD

    May 1, 2018, 00:00

  • Assessing the Potential Impact of Treating Hyperphagia Among People With Prader-Willi Syndrome Using Disease-Specific Qalys

    May 1, 2018, 00:00

  • Adherence Of Outpatient Cancer Patients To Oral Oncolytic Medications Provided By A Specialty Pharmacy

    May 1, 2018, 00:00

  • Systematic Review of the Economic Burden of Antibiotic Resistance

    May 1, 2018, 00:00

  • Epidemiology and Health Related Quality of Life (HRQOL) for Advanced Cervical Cancer- A Targeted Literature Review

    May 1, 2018, 00:00

  • Real-World Healthcare Costs Based On Medication Adherence, Risk Of Stroke And Bleeding In Patients Treated With Novel Anticoagulant Therapy

    May 1, 2018, 00:00

  • The Out-Of-Pocket Cost Burden of Prescription Drugs- A Pan-Canadian Comparison

    May 1, 2018, 00:00

  • Estimating Health Outcomes in HIV Infected Patients Treated with a Dual Regimen of Dolutegravir and Rilpivirine in Europe

    May 1, 2018, 00:00

  • The Impact of Antidepressant Medications on Clinical Outcomes of Patients with Type 2 Diabetes- A Systematic Review

    May 1, 2018, 00:00

  • Locally Advanced Or Metastatic Urothelial Carcinoma In The United States- Economic Burden And Healthcare Utilization

    May 1, 2018, 00:00

  • Assessment Of Change In Quality Of Life (QOL), Carcinoid Syndrome (CS) Symptoms, And Health Care Resource Utilization (HRU) In Cs Patients Treated With Somatostatin Analogs (SSA) -- Results From Longitudinal Patient Surveys

    May 1, 2018, 00:00

  • Preeclampsia Cost of Illness- Maternal and Infant Healthcare Costs

    May 1, 2018, 00:00

  • Emerging Privates- Identifying the Major Markets for Private Healthcare Expenditure

    May 1, 2018, 00:00

  • Real-World Outcomes and Medication Adherence to Disease Modifying Therapies (DMTS) Among Patients with Multiple Sclerosis (MS)

    May 1, 2018, 00:00

  • Is Eunethta Enough? The Remaining Challenges in Navigating the Early European Regulatory and HTA Advice

    May 1, 2018, 00:00

  • American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) For Biotinidase Deficiency (BIOT)- The Influence of Uncertainty Due to Missing Data

    May 1, 2018, 00:00

  • Impact of Digital Remote Health Coaching for Patients with Chronic Conditions on Quality-Adjusted Life-Years

    May 1, 2018, 00:00

  • Extended-Duration VTE Prophylaxis With Orally Administered Betrixaban Saves Cost Compared To Standard-Duration Enoxaparin Across The Inpatient And Outpatient Settings

    May 1, 2018, 00:00

  • Budget Impact Analysis of Niraparib and Olaparub As Maintenance Therapy for Platinum Sensitive, Recurrent Ovarian Cancer In The US

    May 1, 2018, 00:00

  • Utilizing Real-World Data to Inform a Confirmatory Basket Trial Design- Studying Use of Rituximab in Autoimmune Diseases

    May 1, 2018, 00:00

  • Interventional Radiology to Bedside Peripherally Inserted Central Catheter Placement- A U.S. Hospital Cost Analysis

    May 1, 2018, 00:00

  • Transplanting Kidneys from HCV Positive Donors into HCV Negative Recipients in the Era of Direct Acting Antiviral Therapy- A Cost Effectiveness Analysis

    May 1, 2018, 00:00

  • Examining Parkinson’s Disease Psychosis Treatment Outcomes in the Real World- The Insyte Observational Study

    May 1, 2018, 00:00

  • Management of Asymptomatic Term Late Preterm Newborns Exposed to Maternal Intrapartum Fever- A Societal Cost Benefit Analysis of the Proposed “Triple I” Algorithm

    May 1, 2018, 00:00

  • Exploring use of Real World Evidence (RWE) in us Value Assessment Frameworks (VAFS)

    May 1, 2018, 00:00

  • Main Drivers of Direct Healthcare Costs for Osteoarthritis in The US- A Retrospective Private Insurance Claims Analysis Through 2014

    May 1, 2018, 00:00

  • A Systematic Literature Review And Meta-Analysis of Complications Potentially Associated With Single Incision Slings (SIS) for the Treatment of Stress Urinary Incontinence

    May 1, 2018, 00:00

  • What Do We Mean by Patient Engagement? A Qualitative Content Analysis of Current Definitions

    May 1, 2018, 00:00

  • Cost-Effectiveness of a Single Inhaler Triple Therapy vs a Dual Inhaled Corticosteroid Plus Long-Acting Beta Agonist (ICS/LABA) for Patients with Chronic Obstructive Pulmonary Disease (COPD) in the United Kingdom (UK)

    May 1, 2018, 00:00

  • Number Needed to Treat in Patients with Spinal Muscular Atrophy Type 1 Treated with Avxs-101 Relative to Nusinersen

    May 1, 2018, 00:00

  • Immunomodulators and Immunosuppressants for Patients with Relapsing-Remitting Multiple Sclerosis- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Budget Impact of Niraparib As Maintenance Treatment for Medicare Patients with Recurrent Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer Who are in Complete or Partial Response to Platinum-Based Chemotherapy

    May 1, 2018, 00:00

  • Patient Engagement as a Predictor for Health Outcomes and Costs in Multiple Chronic Conditions

    May 1, 2018, 00:00

  • Ablation Versus Antiarrhythmic Drug Treatment Among Patients with Atrial Fibrillation- A Propensity-Matched Analysis

    May 1, 2018, 00:00

  • Types and Number of Strategies that Pharmcists Use to Manage Chronic Pain

    May 1, 2018, 00:00

  • Results Reporting in Clinicaltrials.Gov and Peer-Reviewed Publications for Trials with the Same Sponsor, Drug and Condition

    May 1, 2018, 00:00

  • Budget Impact of Pasireotide Lar for the Treatment of Cushing's Disease from a Finnish Societal Perspective

    May 1, 2018, 00:00

  • The Cost Effectiveness of Sealant Program Between Public and Private Hospital in Chiang Mai Thailand

    May 1, 2018, 00:00

  • The Fathers’ Feeling of Being Prepared and the Experience of Delivery

    May 1, 2018, 00:00

  • Relationship Between Pain Crisis and Life-Threatening Complications in Sickle Cell Disease- A Retrospective Claims Based Study

    May 1, 2018, 00:00

  • Chemotherapy-Induced Nausea And Vomiting (CINV) - Incidence by Age and Sex Among Patients Receiving Oxaliplatin

    May 1, 2018, 00:00

  • Prevalence and Factors Associated with Uptake of the 3-Dose Catch-UP Primary Series of the Tetanus-Diphtheria Vaccine in a Recently Resettled Refugee Population

    May 1, 2018, 00:00

  • Factors Associated with Breast Cancer Screening Among African American Women

    May 1, 2018, 00:00

  • National Trends in Diabetes Medication Use in the United States, 2008-2015

    May 1, 2018, 00:00

  • Analysis of Medication Adherence Among Patients Taking Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C

    May 1, 2018, 00:00

  • Association Between Insurance Type and Level of Care in Community-Living Patients with Alzheimer’s Disease and Related Dementias

    May 1, 2018, 00:00

  • Determinants and Impact of Continuity of Care in Individuals Newly Diagnosed with Chronic Obstructive Pulmonary Disease

    May 1, 2018, 00:00

  • What does “Real World” Evidence Mean? A Review of 2017 Literature

    May 1, 2018, 00:00

  • Minimally-Invasive Spinal Surgery vs Open Surgery for Patients with Posterior Surgery – Analysis of Patient Presentation, Comorbidities and Peri-Operative Outcomes

    May 1, 2018, 00:00

  • Study of Prevalence of Tobacco Use Among Children and Youth in India

    May 1, 2018, 00:00

  • Discounts Offered by first and Subsequent Biosimilars in the US, EU and Latam- Impact Trends of Originator Starting Price, Market Dynamics and Regulations

    May 1, 2018, 00:00

  • Health Care Costs and Utilization Associated with High Risk Prescription Opioid use

    May 1, 2018, 00:00

  • Characterization of Patient Activation, Clinical Assessments, and Patient Reported Outcomes in T2DM Patients

    May 1, 2018, 00:00

  • The Economic Burden of Skin Symptoms in Psoriatic Arthritis

    May 1, 2018, 00:00

  • Is There A Consensus Regarding Clinically Relevant Non-Inferiority Margins Used For Key Oncology Endpoints In Non-Inferiority Oncology Trials?

    May 1, 2018, 00:00

  • The American Neurogastroenterology and Motility Society Gastroparesis Cardinal Symptom Index-Daily Diary (ANMS GCSI-DD)- Assessing the Content Validity in Patients with Idiopathic or Diabetic Gastroparesis

    May 1, 2018, 00:00

  • Medi-Apex- A Retrospective Non-Interventional Study of PD-L1 Prevalence and Clinical Outcomes for Non-Small Cell Lung Cancer (NSCLC) in Asia-Pacific”

    May 1, 2018, 00:00

  • An Analysis of the Applications for Confirmation on Whether to Belong to the Subjects of the New Health Technologies Assessment in Korea

    May 1, 2018, 00:00

  • New Coronary Procedures After Coronary Intervention (PCI ABD CABG) In Brazilian Private Healthcare System- A Rwd Secondary Analysis

    May 1, 2018, 00:00

  • Vascular Access Outcomes- Impact on Quality of Life and Associated Costs Following Surgical or Endovascular Arteriovenous Fistula Creation for Hemodialysis Patients

    May 1, 2018, 00:00

  • Systematic Review of the Cost Effectiveness of Dapagliflozin Used to Treat Patients with Type 2 Diabetes Mellitus

    May 1, 2018, 00:00

  • Biosimilars- Barriers and Opportunities to Market Access in the United States

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of the use of Coblation Technology Versus Mechanical Debridement in Knee Chondroplasty - A UK National Health Service Perspective

    May 1, 2018, 00:00

  • Budget Impact of Adding a New Single Inhaler Triple Therapy (SITT) for the Treatment of Patients with Chronic Obstructive Pulmonary Disease (COPD) in the UK

    May 1, 2018, 00:00

  • A Health Economic Model for Myelodysplastic Syndrome- Systematic Literature Review to Inform Conceptual Model Design

    May 1, 2018, 00:00

  • The Impact of Response at A Landmark on Overall Survival- Implications for the Economic Evaluation of the Value of Immuno-Oncology (I-O) Treatment in Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Dexmedetomidine Compared to Propofol and Midazolam for Short-Term Sedation in the United States

    May 1, 2018, 00:00

  • Diabetes Medication Adherence and Changes in Healthcare Resource use Over Time

    May 1, 2018, 00:00

  • The Burden of Hereditary Transthyretin Amyloidosis on Health-Related Quality of Life

    May 1, 2018, 00:00

  • Complications, Health Care Resource Utilization and Costs Associated with Type III Open Fractures of the Tibial Shaft Requiring Open Reduction and Internal Fixation

    May 1, 2018, 00:00

  • Relationship Of Health Insurance With Tumor Size And Initial Surgical Treatment Among Women Aged 18-64 Diagnosed With Malignant Phyllodes Tumors Of The Breast

    May 1, 2018, 00:00

  • Demographic, Payer, and Clinical Characteristics of Patients Receiving Bevacizumab (BEV) And Ranibizumab (RAN) For Treatment of Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME)

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ceritinib In Previously Untreated ALK-Positive Non-Small Cell Lung Cancer in the United Kingdom

    May 1, 2018, 00:00

  • A Systematic Review of Economic Outcomes Associated With Use of Topical Interventions for Treatment Of Chronic Wounds

    May 1, 2018, 00:00

  • Effect of Non-Adherence on Healthcare Resource Utilization In Fibromyalgia Patients- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Societal Preferences for Funding Orphan Drugs in the United Kingdom- An Application of Person Trade-Off and Discrete Choice Experiment Methods

    May 1, 2018, 00:00

  • A Retrospective Database Analysis of Usage of Chinese Patent Medicine in China in the Years 2015 2016

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Universal Vs Targeted Human Immunodeficiency Virus (HIV) Screening Approaches to Identify New HIV Diagnoses in the Emergency Department (ED)

    May 1, 2018, 00:00

  • Increasing Trend Toward Reporting Significant Digits in Utility Weights – Behavior Implications of “Flat-of-the-Curve” Medicine?

    May 1, 2018, 00:00

  • The Association Between Medication Self-Monitoring Using an Incentivized Digital Health Program and Claims-Based Medication Adherence

    May 1, 2018, 00:00

  • A literature Review of Transradial vs. Transfemoral Lower Extremity Peripheral Artery Interventions

    May 1, 2018, 00:00

  • A Systematic Review of Discrete Choice Experiment and Conjoint Analysis in Measuring Patients’ Preferences for Multiple Sclerosis Treatments

    May 1, 2018, 00:00

  • Early Pregnancy Ondansetron Exposure is Associated with Increased Risk of Structural Birth Defects in Offspring in a Large, Us Population Sample

    May 1, 2018, 00:00

  • Understanding Heart Failure Burden in Middle East Countries- Economic Impact in Egypt, Saudi Arabia and United Arab Emirates

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Costa Rica

    May 1, 2018, 00:00

  • Cost-Effectiveness of Treating Romanian Post-Stroke Patients with Upper Limb Spasticity With Incobotulinumtoxin-A Against Conventional Therapy

    May 1, 2018, 00:00

  • Cost Drivers in Public Drug Plans in Canada, 2016/17

    May 1, 2018, 00:00

  • Validity Of Patient-Reported Outcomes From Columbus, A Randomized Open Label Phase Iii Clinical Trial Of Encorafenib Plus Binimetinib VS Vemurafenib In Advanced Braf-Mutant Melanoma

    May 1, 2018, 00:00

  • A Comparison Of Patient And Caregiver Worries For Acute Myeloid Leukemia

    May 1, 2018, 00:00

  • Efficacy and Safety of Fluticasone Furoate Nasal Spray for Perennial Allergic Rhinitis in Adults and Adolescents- A Systematic Review

    May 1, 2018, 00:00

  • Adherence to Biologic and Conventional Disease Modifying Anti-Rheumatic Drugs in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Effect of Fasting Serum Glucose Change on The Risk of Cardiovascular Disease in Men Without Type2 Diabetes

    May 1, 2018, 00:00

  • Analysis of Health Insurance Coverage by Citizenship Status in the United States

    May 1, 2018, 00:00

  • The Humanistic Burden of Postpartum Depression- A Systematic Literature Review

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Crohn’s Disease- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Survey of the Hungarian Health Care Practitioners’ Economic-Migration and Career Changing Attitude

    May 1, 2018, 00:00

  • Nutritional Situation in Under – 5 in “Montes De Maria”, Post-Conflict Zone in Colombia- 2017

    May 1, 2018, 00:00

  • Conversion of Hypoglycemia Utility Decrements from Categorical Units Reflecting Event History into Event Specific Disutility Scores Applicable to Diabetes Decision Models

    May 1, 2018, 00:00

  • Access to Health Insurance Among Nonelderly Adults with Complex Multimorbidity after Passage of the Affordable Care Act

    May 1, 2018, 00:00

  • Trends and Factors Associated with Respiratory Allergy Conditions Among U.S. Prostate Cancer Patients in 2007-2016

    May 1, 2018, 00:00

  • Self-Reported Experiences of Gender, Race, And Immigration Related Discrimination in Health Economics, Outcomes Research, And Market Access Professions

    May 1, 2018, 00:00

  • Do Commercial Health Care Prices Influence Medicare Spending?

    May 1, 2018, 00:00

  • A Comparison of Amstar and Robis Tools for Methodological Quality Assessment of Systematic Reviews of Alzheimer’s Disease

    May 1, 2018, 00:00

  • Total Mortality Outcome was Increased in an Incident Rheumatoid Arthritis (RA) Cohort Versus Non-Ra Matched Control Subjects at 20- and 30-Year Post-RA Diagnosis Follow-Up, But Not in Those Aged 60 or Older

    May 1, 2018, 00:00

  • Inpatient Cost and Complications of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Hodgkin’s Lymphoma (NHL)

    May 1, 2018, 00:00

  • A Dynamic Approach for Budget Impact Analysis (BIA) in Oncology- Nonmetastatic Castration-Resistant Prostate Cancer (NMCRPC) as an Illustrative Example

    May 1, 2018, 00:00

  • Budget Impact Analysis of Ustekinumab for the Treatment of Moderate to Severe Crohn’s Disease from a Brazilian Private Payer Perspective

    May 1, 2018, 00:00

  • Prescription Fill Rates for Acute and Chronic Medications in Claims-EMR Linked Data

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ceftolozane/Tazobactam as Empiric Therapy for the Treatment of Complicated Urinary Tract Infections in Colombia

    May 1, 2018, 00:00

  • Economic Burden of Cardiometabolic Disorders Among Patients with Asthma

    May 1, 2018, 00:00

  • Real-Life Autologous Stem Cell Transplantation and Overall Survival Rates in Newly Diagnosed Multiple Myeloma Patients- An Analysis Based on a German Claims Dataset

    May 1, 2018, 00:00

  • Inpatient Cost of Acute Care for Severe Burn Patients- Validation of Economic Model for Adults And Children

    May 1, 2018, 00:00

  • Economic Evaluation Of Human Urinary Kallindinogenase For Patients With Acute Ischemic Stroke In China

    May 1, 2018, 00:00

  • Impact of Arkansas Medicaid Expansion Through Premium Purchase on the Utilization and Access to Prenatal Visits

    May 1, 2018, 00:00

  • Comparative Cost Per Response for four Clinical Outcomes of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in a Head-To-Head Randomized Double-Blind Superiority Trial (ADACTA) in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Bealth Care Resource Utilization (HCRU) of Head and Neck Cancers (HNC) in Hungary- A Retrospective Cross-Sectional Analysis of the National Healthcare Services Center Database in 2010-2016

    May 1, 2018, 00:00

  • Budget Impact Analysis of Malaria Vaccine in Children Younger than 5 Years in Rwanda- A Donor Perspective

    May 1, 2018, 00:00

  • Positive Cancer Drug Recommendations By The Pan-Canadian Oncology Drug Review Are Not Without Conditions Placed On Cost-Effectiveness

    May 1, 2018, 00:00

  • Risk of Cardiovascular Disease Among Patients with Hepatitis C Virus (HCV) Infection

    May 1, 2018, 00:00

  • Comparative Effectiveness of Treatments In Epidermal Growth Factor Receptor Mutant (EGFR-MUTANT) Non-Small Cell Lung Cancer (NSCLC) Patients WHO Failed On Prior Targeted Therapies- A Systematic Literature Review (SLR)

    May 1, 2018, 00:00

  • Study of Prescription Errors and Associated Factors in the Geriatric Patient Population of a Tertiary Care Hospital in India

    May 1, 2018, 00:00

  • Use Of Biomarker Testing In Head And Neck Cancers In The United States And EU5

    May 1, 2018, 00:00

  • Modeling the Impact on Clinical Utility, Patient Harms, And Cost of Biomarkers for the Management of Incidentally Detected Pulmonary Nodules

    May 1, 2018, 00:00

  • The Impact of Functional Status and Multi-Morbidity On Surveillance Use Among Medicare Beneficiaries with Bladder Cancer

    May 1, 2018, 00:00

  • Efficiency of The use of Long-Acting Reversible Contraception- A Systematic Review of the Literature

    May 1, 2018, 00:00

  • Expanded Genomic Testing for Pediatric Cancers is Clinically Impactful But Reimbursement Lags Behind

    May 1, 2018, 00:00

  • A Digital Health Platform to Create Personalized Care Experiences for Patients with Chronic Disease

    May 1, 2018, 00:00

  • Cost-Effectiveness of Carbetocin Versus Oxytocin For Prevention of Postpartum Hemorrhage Resulting From Uterine Atony in High-Risk Women in Colombia

    May 1, 2018, 00:00

  • Economic Burden of Opioid Use Among Pregnant Women- Evidence from the Medical Expenditure Panel Survey, 2011-2015

    May 1, 2018, 00:00

  • Cost-Effectiveness of Serial Cervical Length Screening to Prevent Preterm Birth Among High-Risk U.S. Women- A Decision Analysis

    May 1, 2018, 00:00

  • Nimesulide Induced Hepatotoxicity- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • A Comparison of Prophylactic Versus On-Demand Treatment Regimens of Coagulation Factor VIII for Bleeding and Joint Outcomes in Hemophilia a Patients Without Inhibitors- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • How is Real World Data Currently Used by Industry Professionals?

    May 1, 2018, 00:00

  • Drivers of Genomic Precision Medicine Adoption in the US- Payer Preferences

    May 1, 2018, 00:00

  • Cost-Effectiveness of a 10-Year Revaccination with Tetanus Toxoid, Reduced Diphtheria Toxoid, And Acellular Pertussis (TDAP) Vaccine Among Individuals with Pre-Existing Asthma in the United States

    May 1, 2018, 00:00

  • Systematic Review on Clinical and Health Economic Benefit of Using Safe Blood Drawing Device

    May 1, 2018, 00:00

  • Workplace Absenteeism Associated with Cardiovascular Comorbidities Among Patients With Diabetes

    May 1, 2018, 00:00

  • Model-Based Network Meta-Analysis for Time Course Relationships- A Union of two Methodologies

    May 1, 2018, 00:00

  • A Rasch Analysis of Student Pharmacists’ Attitudes Towards Herbal Medications

    May 1, 2018, 00:00

  • Impact of Depression on Healthcare Utilization and Costs Among Individuals with Irritable Bowel Syndrome (IBS) in Multi-State Medicaid Population

    May 1, 2018, 00:00

  • Economic Impact of Hypoglycemic Events in Type 2 Diabetes Patients- A Review of Real-World Evidence

    May 1, 2018, 00:00

  • Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Cost Minimization Analysis of Insulin Glargine 300 U/Ml Vs Glargine 100 U/Ml for the Management of Type 2 Diabetes from A Private and Public Third-Party Payer Perspective in Chile

    May 1, 2018, 00:00

  • Do Models With Better Goodness Of Fit Ensure Less Biased Treatment Effect Estimates?

    May 1, 2018, 00:00

  • Provisional Versus Complex or Tryton Stenting Strategies for Significant Bifurcated Lesions in Patients Undergoing Percutaneous Coronary Intervention- A Systematic Review

    May 1, 2018, 00:00

  • Cost-Effectiveness of Crizotinib for First-Line Treatment in Non-Small Cell Lung Cancer in Ecuador

    May 1, 2018, 00:00

  • Trends in the Texas Prescription Drug Monitoring Program- Registration and Utilization Among Physicians and Pharmacists

    May 1, 2018, 00:00

  • Characterization of Observational Phase IV Studies Submitted to Clinicaltrials.Gov Between 2007 and 2017

    May 1, 2018, 00:00

  • Economic Impact of the use of Rapid Deployment Valve Replacements in Brazil and Colombia

    May 1, 2018, 00:00

  • Relationship Between Early-Life Antibiotic Exposure and Childhood Obesity- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Association Between Hydroxyurea Medication Adherence and Vaso-Occlusive Crisis Events Among Texas Medicaid Enrollees with Sickle Cell Disease

    May 1, 2018, 00:00

  • Cost-Effectiveness of Parenteral Nutrition- A Systematic Literature Review

    May 1, 2018, 00:00

  • Understanding Pulmonary Rehabilitation Guidelines and Programs from an International Perspective

    May 1, 2018, 00:00

  • A Predictive Model to Identify Opioid-Induced Respiratory Depression Among Hospitalized Patients

    May 1, 2018, 00:00

  • Cost of Care in Advanced Non-Small Cell Lung Cancer (ANSCLC) in the Immuno-Oncology (IO) ERA- A Real-World Analysis of Early Data

    May 1, 2018, 00:00

  • Recent Real-World Trends in Management of Systemic Lupus Erythematosus (SLE) by Us Community Rheumatologists

    May 1, 2018, 00:00

  • Challenges in Reimbursement of Biologics in Severe Asthma- A Review of Health Technology Assessments

    May 1, 2018, 00:00

  • Complete Economic Evaluation of the Use of Micronized Progesterone By Vaginal Administration for the Prevention of Preterm Birth in Pregnant Patients with Short Cervix in Mexico

    May 1, 2018, 00:00

  • Trends in Approval of Advanced Therapy Medicinal Products Approved By the US Food And Drug Administration

    May 1, 2018, 00:00

  • Modeled Survival Gains of Patients with Cystic Fibrosis (CF) Aged ≥12 Years Homozygous for the F508dEL Mutation Treated with the CF Transmembrane Conductance Regulator Modulator (CFTRM) Tezacaftor/Ivacaftor (TEZ/IVA)

    May 1, 2018, 00:00

  • Nitag Hears a WHO!

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Hepatocellular Carcinoma (HCC)- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Budget Impact Analysis Of Bosentan For Treatment Of Pediatric Patients With Pulmonary Arterial Hypertension

    May 1, 2018, 00:00

  • CPX-351 for the Treatment of Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC)- An Analysis of Clinical Benefit

    May 1, 2018, 00:00

  • Indicated Preventive Interventions for Depression in Children and Adolescents- A Meta-Analysis and Meta-Regression

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Voretigene Neparvovec for Vision Loss Due to Biallelic Rpe65-Mediated Inherited Retinal Disease

    May 1, 2018, 00:00

  • Drivers of Social Value Exceed Length and Quality of Life- Evidence from Switzerland

    May 1, 2018, 00:00

  • Sustained Improvement in Work Productivity and Activity Impairment in Chronic Spontaneous Urticaria (CSU) Patients with Omalizumab- Results from Xtend-CIU

    May 1, 2018, 00:00

  • Comparison Of Dose Intensity In Clinical Trial And Real World Settings For Niraparib

    May 1, 2018, 00:00

  • A Standardized Cognitive Interview Approach to Ensure Quality in Caregiver-Recorded Videos of Duchenne Muscular Dystrophy Patients’ Physical Function for Clinical Evaluation

    May 1, 2018, 00:00

  • Examining the Impact of Arkansas Medicaid Expansion Through Premium Purchase on Utilization of Preventative Screening Services

    May 1, 2018, 00:00

  • Cost-Effectiveness of Palbociclib Plus Letrozole in the Treatment of HR+/HER2- Advanced or Metastatic Breast Cancer in Ecuador

    May 1, 2018, 00:00

  • Comparison of Adherence, Persistence, and Bleed-Related Event Rates in Patients Diagnosed with Immune Thrombocytopenia and Treated with Thrombopoietin Receptor Agonists

    May 1, 2018, 00:00

  • Caregiver Burden Among Individuals Providing Informal Caregiving to Survivors of Major Adverse Cardiac Event (MACE)- A Systematic Review

    May 1, 2018, 00:00

  • Risk of Death from the Use of Atypical Antipsychotic Drugs for the Treatment of Neuropyschiatric Symptoms of Dementia- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Transition from ICD-9-CM to ICD-10-CM Diagnosis Coding System in the United States – Findings from Hemophilia A

    May 1, 2018, 00:00

  • The Analysis of Missing Data Around the American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) of Maple Syrup Urine Disease (MSUD)

    May 1, 2018, 00:00

  • Association Between Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and Lower Extremity Amputation- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017

    May 1, 2018, 00:00

  • The Patient Experience and Buprenorphine use Among Pregnant and Postpartum Women

    May 1, 2018, 00:00

  • State of the Art and Future Perspectives of Advanced Therapy Medicinal Products in Italy and in The International Arena

    May 1, 2018, 00:00

  • Trends in HTA Submissions for Rare Diseases- Insights from Review of Nice’s Highly Specialized Technology (HST) Assessment Reports

    May 1, 2018, 00:00

  • Defining Polypharmacy As A Count Of Medications- What is the Optimal Cut-Point?

    May 1, 2018, 00:00

  • Evidence Driven Cancer Drug Approvals In Phase II Versus Phase III Clinical Trials Within A Single-Payer Public Healthcare System

    May 1, 2018, 00:00

  • Digital Behaviour Interventions in Rheumatoid Arthritis- A Systematic Literature Review of the Evidence

    May 1, 2018, 00:00

  • Reduction In Hospitalizations and Medical Cost Savings Associated with Early use of Adjunctive Atypical Antipsychotics in Major Depressive Disorder

    May 1, 2018, 00:00

  • A Holistic Approach to Evaluate the Cost-Effectiveness of Pembrolizumab with Multiple Indications- A Norway-Based Example

    May 1, 2018, 00:00

  • A Predictive Model of Antihypertensive Adherence to Medication in Patients with Hypertension in Huangzhuang Community

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Methicillin Resistant Staphylococcus Aureus (MRSA) Medications for MRSA Pneumonia in Japan

    May 1, 2018, 00:00

  • Core Outcome Sets in Clinical Research- What are They and How Can they Help Decision Makers?

    May 1, 2018, 00:00

  • Adherence Issues in Crohn's Disease- How Can Acceptance Measurement Help Understanding Patients' Concerns and Working On Solutions?

    May 1, 2018, 00:00

  • Characterization of Drug Utilization Studies (DUS) Submitted to The European Union (EU) Electronic Register of Post-Authorisation Studies (PAS)

    May 1, 2018, 00:00

  • Contrasting Utilization of Inpatient Hospitalizations and Emergency Department Visits Between Medicaid and Commercially Insured Arkansans

    May 1, 2018, 00:00

  • Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1- A Canadian Cost-Utility Analysis

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Oral Sumatriptan Versus Oral Ergotamine/Caffeine in the Treatment of Acute Migraine Attacks

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Dabigatran Etexilate Compared To Rivaroxaban For Prevention Of Stroke And Systemic Embolism In Patients With Atrial Fibrillation In China

    May 1, 2018, 00:00

  • Hospitalization Lenght of Stay and Costs In Patients with Multiple Myeloma- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Quantifying the Added Societal Value of Public Health Interventions in Reducing Health Inequality

    May 1, 2018, 00:00

  • Long-Term Costs Associated with Anti-Cyclic Citrullinated Peptide Positivity in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Off-Label Drug Use in Children and Adolescents with Depressive Disorder

    May 1, 2018, 00:00

  • Estimation of Supply Side Cost Effectiveness Threshold in Ukraine- Perspective Use in Health Care Decision-Making

    May 1, 2018, 00:00

  • US Payer Perspectives on Value and Comparisons Outside The US- An Interview Study

    May 1, 2018, 00:00

  • Cost and Shelf-Life Implications of Pathogen-Reduced Platelets- A Hospital Budget Impact Model

    May 1, 2018, 00:00

  • Efficacy and Safety of Enzalutamide in Metastatic Prostate Cancer Patients- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Comparative Costs of Dense Breast Cancer Screening and Recall- Tomosynthesis vs. Ultrasound

    May 1, 2018, 00:00

  • A Retrospective Claims Analysis of Bronchodilator Monotherapy Versus Dual Bronchodilator Fixed-Dose Combination in Patients with COPD

    May 1, 2018, 00:00

  • Screening for and Addressing Social Determinants of Health in Managed Care

    May 1, 2018, 00:00

  • Environmental Scan Of High Risk Breast Cancer Programs

    May 1, 2018, 00:00

  • Youth Preferences for Conditional Economic Incentives to Improve HIV Treatment Adheren A Discrete Choice Experiment in South Africa

    May 1, 2018, 00:00

  • Impact of Distal Radius Sterile KIT on Provider Budget in the USA

    May 1, 2018, 00:00

  • Comparative Risk of Musculoskeletal Disorders Among New Users of DPP4 Inhibitors- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Some Novel Methods for Heterogenous Treatment Effect Estimation with An Application To the Association Between Medication Adherence and Resource Utilization

    May 1, 2018, 00:00

  • A Community-Wide Education Program on Drug Addiction- Stakeholder Knowledge, Beliefs, and Opportunities for Interprofessional Collaboration

    May 1, 2018, 00:00

  • College Students' Preferences for Components of a Campus-Sponsored Program to Reduce Nonmedical Use of Prescription Stimulants

    May 1, 2018, 00:00

  • Budget Impact Analysis of Tafluprost/Timolol Maleate for Lowering Intraocular Pressure (IOP) in Adult Patients with Open-Angle Glaucoma or Ocular Hypertension in Bulgaria

    May 1, 2018, 00:00

  • A Systematic Review of the Epidemiology of Alpha-Mannosidosis

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay, Seasonality and Costs in Patients with Influenza Infection- Analysis of US National In-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • Challenges and Applications of Chinese Guidelines for Pharmacoeconomic Evaluations

    May 1, 2018, 00:00

  • Payer Coverage and Evidence Requirements for Oncology Liquid Biopsy Testing in the United States- Current State and Filling The Gaps

    May 1, 2018, 00:00

  • Age Modifies the Effect of Diabetes on Peripheral Lower-Extremity Diseases-Related Hospitalization Costs

    May 1, 2018, 00:00

  • Time To Reimbursement For Oncology Drugs In EU5

    May 1, 2018, 00:00

  • Factors Associated with Non-Persistent Surveillance after Diagnosis of Oral Potentially Malignant Disorders

    May 1, 2018, 00:00

  • Valuation of Preference-Based Measures- Can Existing Preference Data be Used to Select a Smaller Sample of Health States?

    May 1, 2018, 00:00

  • Self-Assessed Life Expectancy Among the Elderly in Developing Countries- Evidence From Côte D’ivoire

    May 1, 2018, 00:00

  • Health Care Resource Utilization and Direct Medical Costs Among Patients Receiving Treatment for Pelvic Fractures

    May 1, 2018, 00:00

  • The Economic Burden of Sphingolopidosis in Korea

    May 1, 2018, 00:00

  • Evaluation Of The Disease-Specific Items On The Eortc In Hepatocellular Carcinoma Patients Treated With Lenvatinib Or Sorafenib

    May 1, 2018, 00:00

  • Comorbidity and Treatment Burden Among HIV-Infected Patients in a US Medicaid Population

    May 1, 2018, 00:00

  • Systematic Assessment of Decision Analytic Models for the Cost Effectiveness of Immunosuppressive Agents Used In Kidney Transplant Patients

    May 1, 2018, 00:00

  • Influenza Vaccination in Diabetes Mellitus- Exploring Patient Burden and Strategies to Increase Uptake

    May 1, 2018, 00:00

  • Accessing Medications in the United States- A Systemic Review of the Challenges and Barriers

    May 1, 2018, 00:00

  • Characterizing Patients with Stage III and IV Non-Small Cell Lung Cancer (NSCLC)- Generating Real World Evidence (RWE) for Decision-Making In Brazil

    May 1, 2018, 00:00

  • Productivity Gains Associated with Treatment with Elagolix For Endometriosis-Associated Pain

    May 1, 2018, 00:00

  • Healthcare Resources Patterns and Cost Analysis of Pulmonary Arterial Hypertension in a Tertiary Care Setting In Mexico City

    May 1, 2018, 00:00

  • Programmed Cell Death Ligand-1 Testing Among Patients With Metastatic Non-Small Cell Lung Cancer- A Multinational Medical Record Review Study

    May 1, 2018, 00:00

  • Patient Perception of Their Doctor and Hospitalization Among Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease

    May 1, 2018, 00:00

  • Cost-Effectiveness of a Technology-Facilitated Depression Care Management Adoption Model in Safety-Net Primary Care Patients with Type 2 Diabetes

    May 1, 2018, 00:00

  • The Prevalence of Comorbidities and Its Association with Poor Glycemic Control in Malaysian Patients with Type 2 Diabetes Mellitus

    May 1, 2018, 00:00

  • Use of Vascular Closure Devices in the Hospital Setting for Percutanous Coronary Procedures and Gender Differences of the Mynx® Vascular Closure Devi Results from a Hospital Claims Analysis

    May 1, 2018, 00:00

  • Cost Effectiveness Analysis of Azacitidine in Patients with Acute Myeloid Leukemia With >30% Blasts and who are Not Candidate for Curative-Intend Chemotherapy

    May 1, 2018, 00:00

  • Cost and Effectivennes of a Screening Algorithm for the Diagnosis of Rheumatoid Arthirits

    May 1, 2018, 00:00

  • Racial/Ethnic Differences in the Treatment of Adolescent Major Depressive Disorders (MDD) Across Healthcare Providers Participating in the Medicaid Program

    May 1, 2018, 00:00

  • Sociodemographic Disparities in Health-Related Quality of Life Within a Safety Net Primary Care Setting and the Clinical Implications of Symptom Management

    May 1, 2018, 00:00

  • Primary Nonadherence to Antiplatelet Therapy after Revascularization

    May 1, 2018, 00:00

  • Comparison of Healthcare Utilization by Disease Modifying Therapy Generation Among Individuals Diagnosed with Multiple Sclerosis after One Year of Initiating Therapy in the United States

    May 1, 2018, 00:00

  • Self-Reported Pain Outcomes of Pharmacists with Chronic Pain

    May 1, 2018, 00:00

  • The Horse(SAS) Now has a Cart – Comparing Sas to Salford System’s Categorization and Regression Tree Procedures

    May 1, 2018, 00:00

  • A Novel Modelling Approach to Evaluate the Cost-Effectiveness of Chronic Obstructive Pulmonary Disease (COPD) Interventions

    May 1, 2018, 00:00

  • Productivity Growth of Skilled Nursing Facilities in Treating Post-Acute-Care-Intensive Conditions

    May 1, 2018, 00:00

  • Giapreza For The Treatment Of Severe Distributive Shock In The Intensive Care Unit- A US Cost-Effectiveness Analysis

    May 1, 2018, 00:00

  • Real-World Data Analysis Of Metastatic Castration-Resistant Prostate Cancer (MCRPC) Treatment Decisions With The Introduction Of Newer Treatment Options

    May 1, 2018, 00:00

  • Motivational Interviewing as a Strategy for Smoking Cessation Among Adolescents-A Systematic Review

    May 1, 2018, 00:00

  • Pregabalin use on Diabetic Neuropathy Patients and the Risk of Heart Failure

    May 1, 2018, 00:00

  • Effectiveness of Korean Medicine Therapy for Parkinson’s Disease Management- National Health Insurance Service-National Sample Cohort (NHIS-NSC)

    May 1, 2018, 00:00

  • Review of Frequently Implemented Patient Reported Outcomes in Current Prostate Cancer Clinical Trials

    May 1, 2018, 00:00

  • Impact of Urine Drug Testing Amongst Patients At Increased Risk of Drug-Drug Interactions

    May 1, 2018, 00:00

  • Cost Per Responder of Secukinumab Compared to Other Biologics in Moderate-To-Severe Plaque Psoriasis in Brazil

    May 1, 2018, 00:00

  • Assessment of Work Loss and Costs Associated with Opioid Abuse- A Retrospective Claims Analysis

    May 1, 2018, 00:00

  • A Real-World Data Analysis Evaluating the Time to Glycemic Control After Initiation of Basal Insulin in Type 2 Diabetic Patients

    May 1, 2018, 00:00

  • Readmission Risk and Antibiotic Treatment Failure Associated with Hospital Acquired Colostrum Difficile

    May 1, 2018, 00:00

  • How Prescription Drug Cost for Disease Modifying Therapy (DMT) Impacts Overall Health Care Spending Among Individuals with Multiple Sclerosis

    May 1, 2018, 00:00

  • An Analytical Framework for Economic Evaluation of Interventions with Effects on Multiple Outcomes, Costs Falling on Different Budgets, and Involving More than One Decision Maker

    May 1, 2018, 00:00

  • The Cost of New Oral Anti-Diabetic Drugs in Canada and Internationally

    May 1, 2018, 00:00

  • Association Between Insurance Type and Patient Activation Among Medicare Beneficiaries with Type 2 Diabetes

    May 1, 2018, 00:00

  • Indirect Costs of Parkinson Disease Health Care in the National Institute of Neurology and Neurosurgery in the Mexico City

    May 1, 2018, 00:00

  • Perceived Value of Health Insurance and Enrollment Decision Among Low-Income Population

    May 1, 2018, 00:00

  • Comparison Of Bleeding Events, Strokes, And Myocardial Infarcts On Warfarin Or Dabigatran For Treatment Of Atrial Fibrillation- Results Of A Real-World Data Analysis

    May 1, 2018, 00:00

  • Leveraging Clinical Fields from a US EMR Database to Identify and Characterize Latent Autoimmune Diabetes in Adults (LADA) in Real World Practice Settings

    May 1, 2018, 00:00

  • Determinants and Pathways of Rehabilitation after Surgical Aortic Valve Replacement- A Population-Based, Retrospective Study with Administrative Data

    May 1, 2018, 00:00

  • Quality of Life and Functional Impairment Results- A Prospective Real-World Dyskinesia Screening Study and Registry in Patients Taking Antipsychotic Agents

    May 1, 2018, 00:00

  • Impact of Affordable Care Act on Medicare Disproportionate Share Hospital (DSH) Payments

    May 1, 2018, 00:00

  • Differences in Alzheimer’s Disease Protectiveness Among Renin-Angiotensin System Acting Anti-Hypertensive Prescription Drugs

    May 1, 2018, 00:00

  • Variation in Characteristics And A1C Outcomes of Patients with Type 2 Diabetes Mellitus (T2DM) Treated with Canagliflozin in Multiple US States- A Descriptive, Retrospective Cohort Study

    May 1, 2018, 00:00

  • Economic Burden Of Locally Advanced Or Metastatic Merkel Cell Carcinoma In The United States- An Analysis Of Electronic Health Records

    May 1, 2018, 00:00
  • «
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59 (current)
  • 60
  • »